Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
about
Leptomeningeal metastasis in breast cancer - a systematic reviewImpact of multimodality approach for patients with leptomeningeal metastases from solid tumorsLeptomeningeal metastases in breast cancer.Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes.Headache in a young woman: leptomeningeal metastasis as the first presentation of underlying breast malignancyNeuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case ReportA case of brain metastases from breast cancer treated with whole-brain radiotherapy and eribulin mesylate.Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival.Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.Clinicopathological Factors Related to the Prognosis of Metastatic Breast Cancer Patients after Development of Brain Metastasis.Carcinomatous meningitis: Leptomeningeal metastases in solid tumorsSurvival following gamma knife radiosurgery for brain metastasis from breast cancer.Methods and results of local treatment of brain metastases in patients with breast cancer.The shifting landscape of metastatic breast cancer to the CNS.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the AnatolianRisk factors and survival outcomes in patients with brain metastases from breast cancer.Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.A nomogram for predicting survival in patients with breast cancer brain metastasis.EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours†
P2860
Q26778946-70AC33F4-4150-4A59-9599-4EE7BBB3995AQ34029965-7CA4933A-82A3-446F-B25D-BE21BDF8A564Q34650605-CCA777C4-E361-4C3F-B49F-2C579044945BQ34762284-B35846B8-51C1-4F93-849C-30EF249DE383Q35237206-646B1701-D84D-4E73-A4F6-108DF81256E7Q35614669-C2AE57C4-4FFA-46C2-8B80-DAE0799FF478Q35927613-31BD5E6D-C416-4016-B12C-FEF2D88772D1Q36199963-B3CBC935-BEC0-4C28-96EF-8C9CF230D1EEQ36287951-135EAEB6-E075-499A-A050-2ADADFB80B4EQ36354078-9B8F5A86-AC46-46BB-A546-A75713084CF8Q36682459-FDFF0C48-C497-4A8E-9538-3D8064A20EEBQ36851197-151ABCEF-2C59-4E87-BEE8-0631090898CAQ36972484-EB7FA183-5F17-46F2-B51B-07BF1FA4587EQ37657651-3D411511-05D9-4FDA-8C94-B3444C6B0851Q38069431-74B827F2-BB7C-4C77-B802-6D2DB2B2BD54Q38230553-D064172B-10E5-4161-AE33-FEF2A077D222Q39126735-FF836E19-4715-4292-B5CA-195DBE9EC630Q41489396-71C19988-1A14-4124-8BF4-0B8E58B177EBQ44625585-9B7D9CBC-ED8F-46D1-8EF6-F7315B72C903Q45757920-94C39D87-C3FF-42C1-9327-82770C9B81BCQ47793228-3E24AB67-095B-49CA-AC93-B75DDB514C0AQ50899949-1D64D1AF-3AEE-4AC6-80BF-5D041E517384Q52905561-E16F0F2A-DFE2-4282-A7A2-2D1039A874A2Q55024723-AC1874FE-42E3-4BBC-83F0-73C076A6C2ADQ57578829-6452EAD6-837D-4C69-9E95-C1387AA5544B
P2860
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Clinical outcome of central ne ...... pending on systemic treatment.
@en
Clinical outcome of central ne ...... pending on systemic treatment.
@nl
type
label
Clinical outcome of central ne ...... pending on systemic treatment.
@en
Clinical outcome of central ne ...... pending on systemic treatment.
@nl
prefLabel
Clinical outcome of central ne ...... pending on systemic treatment.
@en
Clinical outcome of central ne ...... pending on systemic treatment.
@nl
P2093
P2860
P1476
Clinical outcome of central ne ...... pending on systemic treatment.
@en
P2093
Bhumsuk Keam
Dae Seog Heo
Do-Youn Oh
Dong-Wan Kim
Hee-Jun Kim
In Ae Park
Jee Hyun Kim
Sae-Won Han
Se-Hoon Lee
Seock-Ah Im
P2860
P2888
P304
P356
10.1007/S11060-011-0664-8
P577
2011-09-22T00:00:00Z